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Background: Low back pain (LBP) is common in children and adolescents, and it is becoming a public health
concern. In recent years there has been a considerable increase in research studies that examine the prevalence of
LBP in this population, but studies exhibit great variability in the prevalence rates reported. The purpose of this
research was to examine, by means of a meta-analytic investigation, the prevalence rates of LBP in children and
adolescents.
Methods: Studies were located from computerized databases (ISI Web of Knowledge, MedLine, PEDro, IME, LILACS,
and CINAHL) and other sources. The search period extended to April 2011. To be included in the meta-analysis,
studies had to report a prevalence rate (whether point, period or lifetime prevalence) of LBP in children and/or
adolescents (≤ 18 years old). Two independent researchers coded the moderator variables of the studies, and
extracted the prevalence rates. Separate meta-analyses were carried out for the different types of prevalence in
order to avoid dependence problems. In each meta-analysis, a random-effects model was assumed to carry out the
statistical analyses.
Results: A total of 59 articles fulfilled the selection criteria. The mean point prevalence obtained from 10 studies
was 0.120 (95% CI: 0.09 and 0.159). The mean period prevalence at 12 months obtained from 13 studies was 0.336
(95% CI: 0.269 and 0.410), whereas the mean period prevalence at one week obtained from six studies was 0.177
(95% CI: 0.124 and 0.247). The mean lifetime prevalence obtained from 30 studies was 0.399 (95% CI: 0.342 and
0.459). Lifetime prevalence exhibited a positive, statistically significant relationship with the mean age of the
participants in the samples and with the publication year of the studies.
Conclusions: The most recent studies showed higher prevalence rates than the oldest ones, and studies with a
better methodology exhibited higher lifetime prevalence rates than studies that were methodologically poor.
Future studies should report more information regarding the definition of LBP and there is a need to improve the
methodological quality of studies.
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The term low back pain (LBP) was defined by Andersson
[1] as “pain limited to the region between the lower mar-
gins of the 12th rib and the gluteal folds”. LBP is the most
common type of back pain [2], occurring in about 60–80%
of people at some point in their lives [3].
LBP often begins in childhood, and in adolescents
the prevalence is similar to that of adults [4,5]. One* Correspondence: inmaculada.calvo@um.es
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distribution, and reproduction in any mediumcharacteristic of LBP in childhood and adolescence is
its high recurrence and the tendency to reappear with
greater intensity [6]. Although initially intensity is usually
low [7] and it generally lasts for less than a week [7,8],
LBP causes limitations in carrying out activities [9], school
absenteeism and the reduction or ceasing of physical
activity [10].
In recent years there has been a considerable increase
in research studies that examine the prevalence of LBP
in this population [7,10-16], but studies exhibit great
variability in prevalence rates, with estimates ranging
from 1.1% [14] to 66% [7].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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be due to differences among the studies in such factors
as the age of the sample, the sample size, the definition
of LBP, the LBP recall period, the strategy for extracting
data and the methodology used.
The prevalence of a condition is the number of cases
in a specified population at a particular time [17]. The
prevalence is described in terms such as: point prevalence
(the number of persons in a defined population who had a
specified disease or condition at a particular point in time,
usually the time the survey was carried out), period
prevalence (the number of persons who had a specified
disease or condition at any time during a specified time
interval), and lifetime prevalence (the number of persons
who had a specified disease or condition at some point in
their life) [18].
According to the literature on the epidemiology of LBP
in children and adolescents, the prevalence rates increase
with the age of the subjects [11,19-21] and females have
higher prevalence rates than males [12,16,22-24]. Epidemio-
logical studies indicate that the point prevalence is less than
the period prevalence and, in turn, this is less than
the lifetime prevalence [12,25,26].
Several narrative reviews have been published about the
prevalence of LBP in children and adolescents [27-29].
However, to our knowledge, a meta-analysis of the LBP
prevalence in children and adolescents has not yet been
carried out. Thus, the main purpose of this research was to
systematically review the prevalence of LBP obtained
in studies with samples composed by children and/or
adolescents, in order to: (a) obtain estimates of point,
period, and lifetime prevalence rates; (b) determine
whether the heterogeneity exhibited by the prevalence
rates of the studies can be explained by random sam-
pling alone or, on the contrary, the studies present
very discrepant prevalence rates, and (c) in the latter
case, to search for substantive and methodological
characteristics of the studies that can explain this
heterogeneity.
Based on the results of previous research, several
hypotheses were raised: (a) the mean estimate of
point prevalence will be lower than that of period
prevalence and, in turn, this will be lower than that
of lifetime prevalence; (b) the prevalence rates will
increase with the age of the participants in the samples,
and (c) females will present higher prevalence rates
than males.Methods
In order to accomplish our objectives, a systematic review
and a meta-analysis were carried out on observational
studies that reported prevalence rates of LBP in children
and/or adolescents.Selection criteria of the studies
To be included in the meta-analysis, the studies had to
meet the following criteria: (a) the study must be an
observational study (survey research, longitudinal or cross-
sectional design) that reports any prevalence rate of low
back pain in children and/or adolescents (≤ 18 years old);
(b) the sample size had to have at least 50 participants; (c)
studies had to be carried out between 1980 and April of
2011, as previous literature searches carried out by our
research team evidenced an absence of studies that report
LBP prevalence rates for children/adolescents before 1980;
(d) studies had to be written in English, French, Italian,
Spanish, or Portuguese; (e) studies could be published or
unpublished. Cohort, case–control, controlled clinical trials,
and randomized clinical trials were excluded, as they report
incidence rates instead of prevalence rates.
Literature search
To locate studies that met the selection criteria, several
literature searching strategies were used. Firstly, the
following electronic databases were consulted: ISI Web
of Knowledge, MedLine, PEDro, IME, LILACS, and
CINAHL. The search period extended to April 2011,
with the Medical Subject Headings: adolescents, children,
childhood, back pain, low back pain, spinal pain, epidemi-
ology, and prevalence. Secondly, several electronic specia-
lized journals were consulted such as, Spine, Spine Journal,
Pain, European Spine Journal, Fisioterapia, Scandinavian
J Public Health, European Journal of Public Health,
and, finally, the reference lists of the studies recovered
were also consulted.
Two reviewers independently: (a) screened the title and
abstract of each reference to locate potentially relevant
studies, and once hardcopies of the screened papers were
obtained, (b) reviewed them in detail to identify articles
that fulfilled the selection criteria.
The total number of references identified with all of
the searching strategies used was 2,272, of which 2,188
were excluded in a first screening. The main reasons for
deleting these studies were because the participants in
the samples were adults (about 55%), the studies did not
report prevalence rates (about 20%), the studies were
clinical trials (about 15%), or other reasons (about 10%).
The searching process enabled us to select 59 articles that
met the selection criteria, with a total sample size of
125,483 participants. Figure 1 presents the flow chart of the
selection process of the studies.
Data extraction
With the purpose of identifying characteristics of the
studies that may affect the prevalence rates estimated, a
codebook was produced that included a series of poten-
tial moderator variables of the prevalence rates of LBP.
The study characteristics were classified into substantive
Records identified by searching 
databases ISI Web of Knowledge,  














































Figure 1 Flow chart of the selection of studies for the meta-analysis.
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extrinsic variables [30].
The following subject characteristics were coded: (a)
the origin of the sample (school, community, university,
or sport origin); (b) the mean age of the sample (in
years), and (c) the gender distribution of the sample
(percentage of males). Two context characteristics were
coded: the continent and the country where the study
was carried out.
The following methodological characteristics were coded:
(a) the initial sample size of the study; (b) the final sample
size (subjects actually used to calculate the prevalence
rate); (c) the response rate (percentage of people in the
final sample divided by the number of people in the initial
sample); (d) the study design (longitudinal vs. cross-
sectional); (e) the data extraction method (questionnaire,
interview, physical examination); (f) the type of prevalence
reported (point, period, or lifetime prevalence); (g) the
methodological quality of the study, assessed with an
instrument used in previous systematic reviews on theprevalence of LBP [31-33]. This instrument contains 12
items grouped in three clusters focusing on the sample
representativeness, the quality of the data collected, and
the clarity of the definition of LBP, see Additional file 1.
Finally, two extrinsic characteristics were coded: the publi-
cation date (year) and the publication source (published
vs. unpublished).
To assess the reliability of the coding process, two
researchers independently coded 14 studies randomly
selected from the total set of studies (24%). The inconsis-
tencies between the two coders were solved by consensus,
and when these were due to ambiguity in the codebook,
this was corrected. The codebook can be obtained from
the corresponding author upon request. To assess the
coding reliability, intra-class and kappa coefficients were
calculated for the continuous and categorical variables,
respectively. On average, the intra-class correlation was
0.994 (range: 0.98 - 1.0), and the kappa coefficient was
0.989 (range: 0.77 - 1.0), all of which can be considered to
be highly satisfactory [34].
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Three types of prevalence were included in our review:
point, period, and lifetime prevalence. In turn, period
prevalence was classified according to the specific period of
time reported in the study (one and two weeks, 1, 3, 6,
and 12 months). From each study, at least one preva-
lence rate could be obtained. When a study applied a
longitudinal design, only the prevalence rate at the begin-
ning of the study was recorded in our meta-analysis. To
assess the reliability in the calculations of the prevalence
rates, the same 14 studies used to assess the coding reli-
ability of the moderator variables were used. The mean
intra-class correlation was 0.999 (range: 0.996 – 1.0),
which was highly satisfactory [34].
Statistical analysis
As each study could report more than one prevalence rate
(e.g., point and lifetime prevalences), separate meta-
analyses were carried out for the different types of preva-
lence in order to avoid dependence problems. To normalize
the distribution of the prevalence rates, these were trans-
formed by means of the logit event rate: Lp = Ln[p/(1 − p)],
p being the prevalence rate, Ln the natural logarithm, and
Lp the logit event rate. The sampling variance of each logit
event rate, V(Lp), was calculated by means of: V(Lp) = 1/
(np) + 1/[n(1 − p)], with n being the sample size. Once the
statistical analyses were carried out, the results were back-
transformed to prevalence rates in order to facilitate their
interpretation, by means of: p = eLP/(eLP + 1), with e being
the base of the natural logarithm [35].
In each meta-analysis, a random-effects model was
assumed to calculate a mean prevalence rate and a 95%
confidence interval [36]. The random-effects model was
assumed because it is the most realistic assumption
when the studies to be meta-analyzed can be reasonably
considered a representative sample of a population of
potential studies that have been conducted or that can
be conducted in the future about the topic. The
random-effects model allows a higher generalization of
the results than the fixed-effects model [37].
The heterogeneity of the prevalence rates was assessed
with the Q statistic and the I2 index. When the number of
prevalence estimates was large enough (20 or more studies),
a forest plot was constructed. In order to test whether
publication bias might be a threat to the validity of the
prevalence estimates, funnel plots were constructed and
Duval and Tweedie’s trim-and-fill method was applied [38].
When the Q statistic was statistically significant and the
I2 index exhibited a large value (over 25%), then analyses
of potential moderator variables were carried out. How-
ever, due to the small number of studies, these analyses
were applied only for the lifetime prevalence rate, as this
was reported in 30 studies. The analyses of moderator
variables were carried out by assuming a mixed-effectsmodel. For the categorical moderator variables, weighted
ANOVAs were calculated, with the QB statistic assessing
the statistical significance of the moderator variable on
the prevalence rates, and the QW statistic assessing the
model misspecification. For the continuous moderators,
weighted simple meta-regressions were applied, with the
QR statistic testing the statistical significance of the
moderator variable, and the QE statistic assessing the
model misspecification. In all of the moderator analyses,
the proportion of variance accounted for by the mode-
rator variable, R2, was calculated following Raudenbush’s
proposal [39]. In particular, R2 ¼ 1 τ^Res2 =τ^Total2 , with
τ^Res
2 and τ^Total
2 being the estimated residual and total
heterogeneity variances, respectively [40]. In order to find
the subset of moderator variables that can explain most of
the prevalence rates variability, a multiple meta-regression
model (by assuming a mixed-effects model) was adjusted.
The moderator variables included in the model were
selected taking into account the statistical significance
achieved in the previous bivariate analyses. This regression
model allowed us to identify the most relevant study
characteristics to explain the variability exhibited by
the prevalence rates.
The statistical analyses were carried out with the meta-
analysis program Comprehensive Meta-analysis 2.0 [41]
and with the SPSS macros elaborated by D. B. Wilson [42].
The PRISMA checklist was used to check the reporting
quality of the meta-analysis (Additional file 2).Results
Descriptive characteristics of the studies
Fifty-nine articles fulfilled the selection criteria [4,8-12,
14,19-26,43-86], and were carried out between 1984 and
2010, see Figure 1. The individual characteristics of each
of the integrated studies are presented in Additional file 3
(This file contains data collected from other articles
[87-103]).
The sample size distribution was very skewed, with a
median of 622 subjects and minimum and maximum
values of 88 [22] and 34,423 [43], respectively. Most of
the studies were carried out in Europe (42 studies; 73%),
followed by North America (6 studies; 10.2%), Oceania
and Asia with four studies each (6.8%), and Africa with
two studies (3.4%). Only three of the 59 studies had not
been published. Fifty-five studies were written in English,
three in Portuguese, and one in Spanish.
Three subject characteristics were coded: the origin of
the sample, the mean age, and the percentage of males in
the sample. Most of the samples were recruited from
schools (46 studies; 78%), followed by the community
(7 studies, 11.9%). On average, the mean age of the samples
was 13.6 years old (range: 9–18.4) and the mean percentage
of males was 51.1% (range: 41.5% – 100%).
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response rate was 83.8%, and most of the studies used a
cross-sectional design (52 studies, 88.1%). The data extrac-
tion method most commonly used was the questionnaire
(46 studies, 78%), followed by the questionnaire and phy-
sical examination combined (5 studies, 8.5%), the inter-
view (4 studies, 6.8%), the questionnaire and interview
combined (2 studies, 3.4%), and the interview and physical
examination combined (2 studies, 3.4%).
Out of the different types of prevalence, period preva-
lence was the most commonly reported (25 studies,
42.4%), followed by the lifetime and period prevalence
combined (15 studies, 25.4%), the lifetime prevalence
alone (eight studies, 13.5%), the lifetime, period, and
point prevalences combined (five studies, 8.5%), the life-
time and point prevalences combined (three studies,
5.1%), the point prevalence alone (two studies, 3.4%),
and the period and point prevalences combined (one
study, 1.7%).
The methodological quality scores of the included
studies are reported in Additional file 4. The minimum
and maximum scores were 40% and 100%, respectively,
with a mean of 76.7%, and five studies reaching the max-
imum score of 100%.
For the first block of methodological questions con-
cerning the sample representativeness (questions 1, 2
and 3 of Additional file 1), 74.6% of the studies used at
least one of the following conditions: an entire target
population, randomly selected sample, or sample stated
to represent the target population. With regards to
nonresponse, 23.7% of the studies specified at least one
of the following situations: reasons for nonresponse
described, nonresponders described, comparison of
responders and nonresponders, or comparison of sample
and target population. Finally, 86.4% of the studies
reported the response rate.Table 1 Mean prevalences, 95% confidence intervals, and het
Type of prevalence k N Min. Max.
Point prevalence 10 49,124 0.032 0.350
Period prevalence:
1 week 6 9,812 0.097 0.350
2 weeks 1 1,193 0.246 0.246
1 month 14 23,191 0.025 0.398
3 months 2 4,126 0.224 0.513
6 months 7 25,037 0.008 0.420
12 months 13 19,673 0.174 0.603
Lifetime prevalence 30 61,732 0.086 0.648
* p < .001. k: number of studies. N: total sample size. Min. and Max.: minimum and m
confidence limits of the 95% confidence interval around the mean prevalence. Q: h
rates. df: degrees of freedom of the Q statistic. I2: heterogeneity index.In relation to questions related to the quality of the
data (questions 4, 5, 6, 7, 8 and 9 of Additional file 1),
the majority of the studies reported primary data on
LBP (57 studies). LBP data were collected directly from
each child or adolescent in 79.7% of the studies, with the
remaining studies being collected from a proxy. Out of
the 59 studies, 58 used the same mode of data collection
for all participants in the sample.
To collect the data, the studies used different instru-
ments, such as questionnaires (79.7%), interviews (8.5%),
and examinations (11.9%). The instruments had to be
validated or at least its reliability had to be tested.
With regards to the definition of LBP (questions 10,
11 and 12 of Additional file 1), 61% of the studies
applied a precise anatomic delineation of the lumbar
area or made a reference to an easily obtainable article
that contained such specification. A further useful speci-
fication of the definition of LBP was applied in 52.5% of
the studies by means of questions such as the frequency,
duration or intensity, and character of the pain. 96.6% of
the studies used recall periods that were clearly stated
(1 and 2 weeks, 1, 3, 6 and 12 months or lifetime).
Mean prevalence and heterogeneity testing
Table 1 presents the mean rates and 95% confidence
intervals for each one of the types of prevalence, as well
as the minimum and maximum prevalence rates, and
the heterogeneity statistics (Q and I2). The mean point
prevalence obtained from 10 studies was 0.120 (95%
confidence limits: 0.09 and 0.159). As expected, period
and lifetime prevalence rates were higher than point
prevalence. Thus, the mean period prevalence at
12 months obtained from 13 studies was 0.336 (95%
confidence limits: 0.269 and 0.410), whereas the mean
period prevalence at one week obtained from six studies
was 0.177 (95% confidence limits: 0.124 and 0.247). Theerogeneity statistics
p+ 95% C. I. Q df I
2
pl pu
0.120 0.090 0.159 546.87* 9 98.3
0.177 0.124 0.247 156.56* 5 96.8
0.246 0.222 0.271 – – –
0.183 0.128 0.255 1618.85* 13 99.2
0.355 0.134 0.662 187.49* 1 99.5
0.177 0.088 0.324 2197.00* 6 99.7
0.336 0.269 0.410 997.00* 12 98.8
0.399 0.342 0.459 4957.79* 29 99.4
aximum prevalence rates. p+: mean prevalence. pl and pu: lower and upper
eterogeneity statistic to test the homogeneity hypothesis of the prevalence
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0.399 (95% confidence limits: 0.342 and 0.459). Figure 2
presents a forest plot of the 30 lifetime prevalence rates.
The lifetime prevalence estimates exhibited a large
heterogeneity, with such extreme minimum and maximum
values as 0.086 [52] and 0.648 [9], respectively.
For all of the types of prevalence, the heterogeneity Q
statistic reached statistical significance (p < .001) and all
of the I2 indices were over 95% (see Table 1). Therefore,
an analysis of the potential influence of moderator vari-
ables was in order. However, the small number of stu-
dies that reported point and period prevalence rates
discouraged the application of additional analyses on
these rates. Therefore, moderator analyses were carried
out for the lifetime prevalence rates only.
Analysis of publication bias
Out of the 30 studies that reported lifetime prevalence esti-
mates, 29 of them were published studies. In order to check
whether publication bias might be biasing the estimated
mean prevalence, a funnel plot was constructed, as
presented in Figure 3. As the figure shows, a slightly higher
concentration of prevalence estimates was on the right side
of the mean prevalence leading to a slight asymmetry of the
funnel plot. By applying Duval and Tweedie’s trim-and-fillStudy ID                                             p pl pu
Balagué et al. (1988)                             0,345 0,320 0,371
Balagué et al. (1993) 0,336 0,255 0,428
Balagué et al. (1994)                             0,210 0,191 0,230
Balagué et al. (1995)                             0,510 0,471 0,549
Bejia et al. (2005)                               0,274 0,240 0,310
Burton et al. (1996)                              0,116 0,080 0,166
Çakmak et al. (2004)                              0,325 0,275 0,380
Coelho et al. (2005)                              0,481 0,414 0,549
Ebrall (1994)    0,403 0,365 0,442
Fairbank et al. (1984)                            0,086 0,063 0,116
Gunzburg et al. (1999)                            0,360 0,314 0,409
Hangai et al. (2010)                              0,616 0,602 0,630
Harreby et al. (1999)                             0,589 0,563 0,615
Hestbaek et al. (2004)                            0,320 0,309 0,331
Jones et al. (2004)                               0,402 0,360 0,446
Kristensen & Ommundsen (2001) 0,630 0,559 0,696
Kujala et al. (1992)                              0,280 0,211 0,361
Murphy et al. (2007)                              0,550 0,512 0,587
Newcomer & Sinaki (1996)                          0,510 0,411 0,608
Olsen et al. (1992)                               0,304 0,279 0,330
Prendeville & Dockrell (1998)                     0,415 0,347 0,487
Prista et al. (2004)                              0,280 0,223 0,346
Ratliffe (2010)    0,564 0,523 0,604
Salminen et al. (1992)                            0,303 0,279 0,328
Sato et al. (2008)                                0,288 0,283 0,293
Shehab et al. (2004)                              0,578 0,529 0,626
Sjölie & Ljunggren (2001)                         0,646 0,541 0,739
Skoffer et al. (2007) 0,648 0,607 0,687
Staes et al. (2003)                               0,603 0,592 0,614
Troussier et al. (1994)
Mean prevalence (RE model)
0,368 0,341 0,396
0,399 0,342 0,459
Figure 2 Forest plot of the lifetime prevalence rates. p: prevalence rat
confidence interval around the mean prevalence rate. The last row in t
random-effects model.method [38], three additional prevalence estimates should
be imputed to the set of original prevalence estimates to
achieve symmetry in the funnel plot. The mean prevalence
rates obtained with the 30 original prevalence rates and
after imputing three estimated prevalences to the original
ones were very similar: 0.399 and 0.372, respectively.
Therefore, we can discard publication bias as a threat to
the validity of the estimated mean lifetime prevalence.
Similar analyses were carried out for the other types of
prevalence that were represented in the meta-analysis with
at least 10 prevalence estimates. This was the case for point
prevalence and for one and 12 months period prevalences.
Point prevalence exhibited a funnel plot that was very close
to symmetry, and only one new prevalence rate had to be
imputed to the 10 original prevalence estimates to adjust
the funnel plot to symmetry, leading to original (p+ = 0.120)
and adjusted (p+adj = 0.103) mean point prevalences that
were very similar. With regards to one month period preva-
lence, the trim-and-fill method did not have to imput any
new prevalence rates to achieve symmetry in the funnel
plot. On the contrary, the 12 month period prevalence
needed to add five new prevalence rates on the left side of
the funnel plot to achieve symmetry, leading to a clear
decrease in the mean prevalence from 0.336 (with the 13
original prevalence rates) to 0.245 (when imputing five newPrevalence and 95% CI
0 0,50 1
es. pl and pu: lower and upper confidence limits of the 95%
he figure presents the mean prevalence assuming a

















Figure 3 Funnel plot of the lifetime prevalence logits. The three full circles are imputed logits by means of the Duval and Tweedie’s
trim-and-fill method.
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the point and one month period prevalences do not seem
to be affected by publication bias, the 12 month period
prevalence showed an overestimation of the population
prevalence rate.
Analyzing moderator variables
As mentioned above, the analysis of moderator variables
was carried out for the lifetime prevalence rates only, as
the other types of prevalence were represented in the
meta-analysis with a small number of estimates (under 20).
Tables 2 and 3 present the results of applying ANOVAs
and simple meta-regressions on the subject characteristicsTable 2 Results of the weighted ANOVAs of qualitative mode
Moderator variable k p+
Continent:
Europe 21 0.390












k: number of studies. p+: mean prevalence. pl and pu: lower and upper confidence l
between-categories statistic to test the influence of the moderator variable on the
misspecification. R2: proportion of variance accounted for by the moderator variablecoded from the studies. The mean age of the participants
in the samples exhibited a positive, statistically significant
relationship with the prevalence rates, with a 45.7% of
variance accounted for (Table 3). Figure 4 presents a
dispersion diagram that illustrates this relationship.
Other subject characteristics did not reach a statistically
significant relationship with the prevalence rates, such as
the origin of the sample (Table 2) and the percentage of
males in the sample (Table 3).
The continent where the study had been carried out did
not affect prevalence rates (Table 2). However the publica-
tion year presented a statistically significant relation-
ship with the prevalence rates, with the most recentrator variables on the lifetime prevalence estimates
95% C. I. ANOVA results
pl pu
0.314 0.472 QB(4) = 1.95, p = .745; R
2 = 0.0




0.333 0.467 QB(3) = 0.87, p = .833; R
2 = 0.0
0.197 0.638 QW(26) = 3833.03, p < .001
0.249 0.703
0.085 0.619
0.354 0.471 QB(1) = 0.36, p = .546; R
2 = 0.143
0.243 0.507 QW(25) = 2345.19, p < .001
imits of the 95% confidence interval around the mean prevalence. QB:
prevalence rates. QW: within-categories statistic to test the model
.
Table 3 Results of the weighted meta-regressions of
continuous moderator variables on the lifetime
prevalence estimates
Moderator variable k bj QR p QE p R
2
Mean age (years) 30 0.104 5.10 .024 2017.26 < .001 0.457
Gender (% of males) 27 0.008 0.34 .557 4819.51 < .001 0.0
Response rate 27 −0.023 2.94 .086 4807.91 < .001 0.0
Quality scale (0–100) 30 0.019 6.21 .013 2886.94 < .001 0.348
Publication year 30 0.062 9.82 .002 4957.61 < .001 0.0
k: number of studies. bj: regression coefficient of the moderator variable. QR:
statistic to test the influence of the moderator variable on the prevalence
rates. QE: statistic to test the model misspecification. R
2: proportion of variance
accounted for by the moderator variable.
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ones (Table 3).
Several methodological variables were also coded in order
to examine their potential influence on the prevalence rates.
Thus, the data extraction method did not show a statistical
relationship with the prevalence rates (Table 2), although
the percentage of variance accounted for was not negligible
at 14.3%, and the questionnaires (p+ = 0.411) giving slightly
higher prevalence rates than the interviews (p+ = 0.365).
The response rate did not show a statistical relationship
with the prevalence rates (Table 3). However, with 34.8% of
variance accounted for, the total score of the scale used to
assess the methodological quality of the studies exhibited a
positive, statistically significant relationship with the preva-
lence rates, that is, studies with a better methodology
tended to show higher lifetime prevalence rates than studies
that were methodologically poor (Table 3).
Table 4 presents the results of analyzing the influence of
each item of the methodological quality scale on the
lifetime prevalence rates. Out of the twelve quality
criteria, two of them showed a statistically significant
relationship with the prevalence rates. One of them
was whether the non response rate was described in
the study (p = .036, R2 = 0.676), with higher prevalence


























Figure 4 Dispersion diagram of the simple meta-regression of the meother one was whether the study clearly defined the
specific area of pain (p < .001, R2 = 0.376), with higher
prevalence rates in the studies with a clear specification of
the area of pain.
An explanatory model
Several substantive and methodological characteristics of
the studies showed a statistical relationship with the lifetime
prevalence rates, so a multiple regression model can offer a
predictive model of the expected prevalence under certain
conditions. The predictor variables included in the model
were the mean age of the participants in the sample, the
publication year, and two methodological variables: the total
score on the quality scale (0–100) and the quality item
“delimitation of pain” (Yes, 1; No, 0). As shown in Table 5,
the predictive model reached a statistically significant rela-
tionship with the prevalence rates (p < .001, R2 = 0.438).
Two of the four predictive variables showed a statistically
significant relationship with the prevalence rates once the
other predictors were controlled: the delimitation of pain
(p = .041) and the publication year (p = .013). With the re-
gression coefficients shown in Table 5, it is possible to make
predictions about what is the expected lifetime prevalence
under certain conditions. The model was however misspe-
cified, so other study characteristics may be influencing the
lifetime prevalence rates obtained in the studies.
Discussion
The aim of this research was to examine, by means of a
meta-analytic investigation, the prevalence rates of LBP in
children and adolescents, as well as to search for characte-
ristics of the studies that can explain the heterogeneity
exhibited by the prevalence rates. With this purpose, a total
of 59 studies fulfilled our selection criteria and were
included in our meta-analysis.
The results confirmed the hypothesis that the lifetime
prevalence is higher than the period prevalence and, in turn
this is higher than the point prevalence. These results coin-
cide with those obtained by Louw et al. [33] that detectedge (years)
13,70 14,83 15,96 17,08 18,21 19,34
an age of the subjects and the logit prevalence rates.
Table 4 Results of the weighted ANOVAs of quality items on the lifetime prevalence estimates
Quality item k p+ 95% C. I. ANOVA results
pl pu
Target population described:
Yes 21 0.416 0.346 0.489 QB(1) = 0.77, p = .380; R
2 = 0.0
No 9 0.358 0.260 0.469 QW(28) = 4942.26, p < .001
Non response described:
Yes 5 0.486 0.401 0.572 QB(1) = 4.42, p = .036; R
2 = 0.676
No 20 0.384 0.343 0.427 QW(23) = 1162.44, p < .001
Response rate reported:
Yes 27 0.403 0.343 0.467 QB(1) = 0.21, p = .648; R
2 = 0.0
No 3 0.358 0.202 0.551 QW(28) = 4910.99, p < .001
Direct reporting from subjects:
Yes 26 0.411 0.344 0.480 QB(1) = 0.87, p = .352; R
2 = 0.0
No 4 0.326 0.190 0.498 QW(28) = 4853.39, p < .001
Validated instrument:
Yes 26 0.400 0.339 0.464 QB(1) = 1.32, p = .250; R
2 = 0.015
No 3 0.517 0.332 0.698 QW(27) = 4754.11, p < .001
Delimitation of pain:
Yes 20 0.472 0.413 0.532 QB(1) = 17.98, p < .001; R
2 = 0.376
No 10 0.266 0.205 0.338 QW(28) = 2192.08, p < .001
Specification of pain:
Questionnaire 16 0.399 0.316 0.487 QB(1) = 0.00, p = .999; R
2 = 0.0
Interview 14 0.399 0.311 0.494 QW(28) = 4635.79, p < .001
k: number of studies. p+: mean prevalence. pl and pu: lower and upper confidence limits of the 95% confidence interval around the mean prevalence. QB:
between-categories statistic to test the influence of the moderator variable on the prevalence rates. QW: within-categories statistic to test the model
misspecification. R2: proportion of variance accounted for by the moderator variable. Five of the 12 quality items were not included in the table due to one of
their categories being represented by one study only or by none (survey designed for studying prevalence rates, data collection was uniform, validated interview,
validated exam, and memory period clear).
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adolescents of 12%, 33%, and 36%, respectively.
The hypothesis that the prevalence rate would increase
with the age of the participants in the samples was
confirmed by our results. These findings are in line with
those obtained by Balagué et al. [11] and Jones et al. [19].
Balagué et al. [11] reported lifetime prevalences of 16% andTable 5 Results of the multiple meta-regression on the
lifetime prevalence estimates
Predictor variable bj Z p Results of the full model
Constant −80.160 −2.49 .013
Delimitation of pain −0.516 −2.05 .041 QR(4) = 27.24, p < .001
Mean age (years) 0.029 0.55 .584 R2 = 0.438
Quality scale (0–100) 0.005 0.63 .531 QE(25) = 1306.02, p < .001
Publication year 0.040 2.49 .013
bj: partial regression coefficient of each moderator variable. Z: statistic to test
the influence of each moderator variable on the prevalence rates. QR: statistic
to test the statistical significance of the full model. QE: statistic to test the
model misspecification. R2: proportion of variance accounted for by the
moderator variables.58% for children and adolescents, respectively, and Jones
et al. [19] reported lifetime prevalences of 18.2% for 10 years
old children and of 65.6% for 16 year old adolescents.
With regards to gender, authors such as Shebad et al.
[20] and Kovacs et al. [62] found higher lifetime preva-
lences for women (64.7% and 69.3%, respectively) than for
men (50.8% and 50.9%, respectively). On the contrary,
Newcomer et al. [72] reported higher prevalence rates for
men than for women (57% and 44%, respectively). Finally,
Olsen et al. [74] did not find relevant differences between
the lifetime prevalence rates for men and women (30.7%
and 30%, respectively). The results of our meta-analysis
exhibited a nonstatistically significant relationship between
gender and lifetime prevalence and, as a consequence, our
hypothesis of a larger prevalence for women than for men
was not confirmed.
The large heterogeneity found in all types of prevalence
indicates the existence of characteristics of the studies
causing this variability. The publication year influenced
the lifetime prevalence rates, with the higher prevalence
rates being reported in the most recent studies. This result
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model publication year was one of the two predictors that
achieved a statistically significant relationship with the
lifetime prevalence, once controlled the methodological
quality of the studies, the delimitation of pain, and the
mean age of the sample. However, what our analyses do
not enable us to determine are the reasons of that increase
in the prevalence rates. Thus, it could be that children are
changing their activity level or they are more overweight;
it could be that the actual prevalence has not changed but
the reporting has; or it could be that the questions used to
assess the prevalence have changed. This point would
need more research. Regarding the methodological quality
of the studies, the studies with a better quality tended to
show higher lifetime prevalence rates than studies that
were methodologically poor.
The most common methodological shortcomings of the
studies included in the review were the lack of a clear defi-
nition and delimitation of LBP and the absence of impor-
tant specifications of LBP such as the frequency of
episodes, its intensity and duration. In particular, out of the
studies published between 1980 and 2001, only 40.9%
reported a clear definition of LBP, whereas in the most
recent studies (from 2002 to date) this percentage was 73%.
With regards to the LBP specifications, the percentage was
71% for studies published in the last 10 years and 29% for
those that were not published in the last 10 years.
Limitations of the meta-analysis
It is important to note some limitations of our meta-ana-
lysis. The small number of studies that reported point and
period prevalence rates discouraged the analysis of mode-
rator variables and, as a consequence, this kind of analysis
was applied for lifetime prevalence rates only. On the other
hand, the absence of a more detailed description in the
primary studies about such important aspects as the exact
area of pain caused uncertainty in our coding process.
Implications for clinical practice
The results of our meta-analysis have important conse-
quences for professionals. Our finding of higher prevalence
rates in the most recent studies suggests that LBP is a
problem that is increasing in childhood and adolescence.
As a consequence, more attention should be devoted to
develop and apply prevention programs for young children
in order to break this trend. On the other hand, our finding
of higher prevalence rates in the studies with older subjects
points to the need for efforts towards an early detection of
LBP in children and adolescents.
Implications for future research
Our results enable us to make recommendations for future
research in this field. Firstly, it is advisable that future stu-
dies report more information regarding the definition ofLBP. Issues relating to the exact area of pain, the frequency
of episodes, their intensity, and the duration need to
be specified. Secondly, there is a need to improve the
methodological quality of studies in order to avoid threats
against the representativeness of the samples and the
internal validity of the studies. Finally, studies should report
prevalence rates of LBP disaggregated by age and sex.
Conclusion
In conclusion, the most recent studies seem to show higher
prevalence rates than the oldest ones, and studies with a
better methodology tend to show higher lifetime prevalence
rates than studies that are methodologically poor.
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